Literature DB >> 3906923

Immunological evaluation of cell-mediated and humoral immunity in Thai patients with cerebral and non cerebral Plasmodium falciparum malaria: II. Evolution of serum levels of immunoglobulins, antimalarial antibodies, complement fractions and alpha interferon.

A Fribourg-Blanc, P Druilhe, P Brasseur, A Rhodes-Feuillette, J J Ballet, S Tharavanij.   

Abstract

In Thai patients with Plasmodium falciparum malaria, IgG and IgM values were elevated, whereas IgA levels were within normal ranges. No association of Ig values with parasitaemia was noted. IFA-IgM antibody levels were lower in cerebral malaria (CM) than in the non cerebral malaria (NCM) group. IFA-IgG antibodies were present in all patients. The mean C3 and C4 values were similar among patients from the CM and NCM groups. Interferon like activity was detected in all CM and NCM patients, and no correlation was found with either antimalarial antibodies, complement or parasitaemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3906923

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  3 in total

1.  Severe malaria in Gambian children is not due to lack of previous exposure to malaria.

Authors:  O A Erunkulu; A V Hill; D P Kwiatkowski; J E Todd; J Iqbal; K Berzins; E M Riley; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions.

Authors:  J Iqbal; P Perlmann; B M Greenwood; K Berzins
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

3.  Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study.

Authors:  Eduard Rovira-Vallbona; Gemma Moncunill; Quique Bassat; Ruth Aguilar; Sonia Machevo; Laura Puyol; Llorenç Quintó; Clara Menéndez; Chetan E Chitnis; Pedro L Alonso; Carlota Dobaño; Alfredo Mayor
Journal:  Malar J       Date:  2012-05-30       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.